Abstract
Soluble amyloid-β oligomers (Aβo) trigger Alzheimer@s disease (AD) pathophysiology and bind with high affinity to cellular prion protein (PrPC). At the postsynaptic density (PSD), extracellular Aβo bound to lipid-anchored PrPC activates intracellular Fyn kinase to disrupt synapses. Here, we screened transmembrane PSD proteins heterologously for the ability to couple Aβo-PrPC with Fyn. Only coexpression of the metabotropic glutamate receptor, mGluR5, allowed PrPC-bound Aβo to activate Fyn. PrPC and mGluR5 interact physically, and cytoplasmic Fyn forms a complex with mGluR5. Aβo-PrPC generates mGluR5-mediated increases of intracellular calcium in Xenopus oocytes and in neurons, and the latter is also driven by human AD brain extracts. In addition, signaling by Aβo-PrPC-mGluR5 complexes mediates eEF2 phosphorylation and dendritic spine loss. For mice expressing familial AD transgenes, mGluR5 antagonism reverses deficits in learning, memory, and synapse density. Thus, Aβo-PrPC complexes at the neuronal surface activate mGluR5 to disrupt neuronal function
| Original language | English |
|---|---|
| Pages (from-to) | 887-902 |
| Number of pages | 16 |
| Journal | Neuron |
| Volume | 79 |
| Issue number | 5 |
| DOIs | |
| State | Published - 4 Sep 2013 |
Bibliographical note
Funding Information:We thank Yiguang Fu and Stefano Sodi for excellent technical support. We thank Xinran Liu of the Yale Center for Cell Imaging for advice on synapse ultrastructure analysis. S.M.S. is a cofounder of Axerion Therapeutics, seeking to develop NgR- and PrP-based therapeutics. H.B.N. is an Ellison Medical Foundation AFAR Postdoctoral Fellow and S.M.S. is a member of the Kavli Institute for Neuroscience at Yale University. We acknowledge support from the National Institutes of Health to S.M.S., A.J.K., and T.W., and from the Falk Medical Research Trust and the Alzheimer’s Association to S.M.S.